Reported number of people receiving antiretroviral therapy in Congo
Congo: Reported number of people receiving antiretroviral therapy was 46,819 in 2025. ◆ Volatile
Reported number of people receiving antiretroviral therapy in Congo, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for reported number of people receiving antiretroviral therapy in Congo is 46,819, measured in 2025. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 6.2% on the previous year and up 126.4% over ten years.
Over the whole period, reported number of people receiving antiretroviral therapy in Congo peaked at 46,819 in 2025 and was at its lowest, 57, in 2000.
That places Congo 56th out of 143 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Reported number of people receiving antiretroviral therapy in Congo, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 57 | — |
| 2001 | 114 | +100.0% |
| 2002 | 269 | +136.0% |
| 2003 | 464 | +72.5% |
| 2004 | 464 | +0.0% |
| 2005 | 2,788 | +500.9% |
| 2006 | 3,186 | +14.3% |
| 2007 | 4,716 | +48.0% |
| 2008 | 9,404 | +99.4% |
| 2009 | 12,169 | +29.4% |
| 2010 | 14,870 | +22.2% |
| 2011 | 16,881 | +13.5% |
| 2012 | 17,234 | +2.1% |
| 2013 | 19,563 | +13.5% |
| 2014 | 19,346 | -1.1% |
| 2015 | 20,682 | +6.9% |
| 2016 | 22,083 | +6.8% |
| 2017 | 23,332 | +5.7% |
| 2018 | 24,678 | +5.8% |
| 2019 | 26,030 | +5.5% |
| 2020 | 27,371 | +5.2% |
| 2021 | 29,487 | +7.7% |
| 2022 | 34,061 | +15.5% |
| 2023 | 38,098 | +11.9% |
| 2024 | 44,097 | +15.7% |
| 2025 | 46,819 | +6.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3,363 | 57 | 12,169 | 10 |
| 2010s | 20,470 | 14,870 | 26,030 | 10 |
| 2020s | 36,656 | 27,371 | 46,819 | 6 |
Countries ranked near Congo
More health data for Congo
- Un projection of annual infant deaths, annual growth rate -0.4813 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9705 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 759.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,688 deaths (2100)
- Population ages 30-34, female, annual growth rate 1.78 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0314 units per person (2025)
- Population ages 30-34, male, annual growth rate 1.84 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0315 units per person (2025)
Frequently asked questions
- What is reported number of people receiving antiretroviral therapy in Congo?
- Reported number of people receiving antiretroviral therapy in Congo was 46,819 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest reported number of people receiving antiretroviral therapy recorded in Congo?
- The highest recorded value was 46,819 in 2025.
- What is the lowest reported number of people receiving antiretroviral therapy recorded in Congo?
- The lowest recorded value was 57 in 2000.
- How does Congo rank for reported number of people receiving antiretroviral therapy?
- Congo ranks 56th out of 143 countries with data for 2025.
- Is reported number of people receiving antiretroviral therapy rising or falling in Congo?
- Over the last ten years it is up 126.4%. The long-run trend across the full record is volatile.
- Where does this Congo data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Reported number of people receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).